Primer on the Pathogenesis of Severe COVID-19: Part Two

In the following continuation article, the author will expand on how the mechanisms discussed in Part One capitalise on host characteristics to produce the organ specific damage seen in severe coronavirus disease (COVID-19), with specific reference to pulmonary and cardiac manifestations. Pneumonia...

Full description

Bibliographic Details
Main Author: Thomas J. Walsh
Format: Article
Language:English
Published: European Medical Journal 2020-12-01
Series:European Medical Journal
Subjects:
Online Access:https://www.emjreviews.com/microbiology-infectious-diseases/article/primer-on-the-pathogenesis-of-severe-covid-19-part-two/
id doaj-97456c50c1f04392a5a9a6a2d2cc3af6
record_format Article
spelling doaj-97456c50c1f04392a5a9a6a2d2cc3af62021-05-06T09:01:40ZengEuropean Medical JournalEuropean Medical Journal2397-67642020-12-01545665Primer on the Pathogenesis of Severe COVID-19: Part TwoThomas J. Walsh0Rheumatology Department, Harrogate and District Hospital, Lancaster Park Road, Harrogate, UKIn the following continuation article, the author will expand on how the mechanisms discussed in Part One capitalise on host characteristics to produce the organ specific damage seen in severe coronavirus disease (COVID-19), with specific reference to pulmonary and cardiac manifestations. Pneumonia is the primary manifestation of COVID-19; presentation varies from a mild, self-limiting pneumonitis to a fulminant and progressive respiratory failure. Features of disease severity tend to directly correlate with patient age, with elderly populations faring poorest. Advancing age parallels an increasingly pro-oxidative pulmonary milieu, a consequence of increasing host expression of phospholipase A2 Group IID. Virally induced expression of NADPH oxidase intensifies this pro-oxidant environment. The virus avails of the host response by exploiting caveolin-1 to assist in disabling host defenses and adopting a glycolytic metabolic pathway to self-replicate. Although not a cardiotropic virus, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) can induce arrhythmias, a myocarditis-like syndrome, and myocardial infarction. Monocyte activation as a consequence of a surge of cytokine expression is the driver of these processes. Induced expression of cluster of differentiation 147 (CD147) and TNF-α may also have a role. SARS-CoV-2 fluently harnesses the immune mechanisms of the host to its advantage, rendering it a formidable systemic pathogen. Future effective treatments are contingent upon improved aetiological understanding. https://www.emjreviews.com/microbiology-infectious-diseases/article/primer-on-the-pathogenesis-of-severe-covid-19-part-two/angiotensin-converting enzyme 2 (ace2)cluster of differentiation (cd) 147coronavirus disease (covid-19)myocarditisnadph oxidasepneumoniaprotein kinase r (pkr)severe acute respiratory syndrome (sars)
collection DOAJ
language English
format Article
sources DOAJ
author Thomas J. Walsh
spellingShingle Thomas J. Walsh
Primer on the Pathogenesis of Severe COVID-19: Part Two
European Medical Journal
angiotensin-converting enzyme 2 (ace2)
cluster of differentiation (cd) 147
coronavirus disease (covid-19)
myocarditis
nadph oxidase
pneumonia
protein kinase r (pkr)
severe acute respiratory syndrome (sars)
author_facet Thomas J. Walsh
author_sort Thomas J. Walsh
title Primer on the Pathogenesis of Severe COVID-19: Part Two
title_short Primer on the Pathogenesis of Severe COVID-19: Part Two
title_full Primer on the Pathogenesis of Severe COVID-19: Part Two
title_fullStr Primer on the Pathogenesis of Severe COVID-19: Part Two
title_full_unstemmed Primer on the Pathogenesis of Severe COVID-19: Part Two
title_sort primer on the pathogenesis of severe covid-19: part two
publisher European Medical Journal
series European Medical Journal
issn 2397-6764
publishDate 2020-12-01
description In the following continuation article, the author will expand on how the mechanisms discussed in Part One capitalise on host characteristics to produce the organ specific damage seen in severe coronavirus disease (COVID-19), with specific reference to pulmonary and cardiac manifestations. Pneumonia is the primary manifestation of COVID-19; presentation varies from a mild, self-limiting pneumonitis to a fulminant and progressive respiratory failure. Features of disease severity tend to directly correlate with patient age, with elderly populations faring poorest. Advancing age parallels an increasingly pro-oxidative pulmonary milieu, a consequence of increasing host expression of phospholipase A2 Group IID. Virally induced expression of NADPH oxidase intensifies this pro-oxidant environment. The virus avails of the host response by exploiting caveolin-1 to assist in disabling host defenses and adopting a glycolytic metabolic pathway to self-replicate. Although not a cardiotropic virus, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) can induce arrhythmias, a myocarditis-like syndrome, and myocardial infarction. Monocyte activation as a consequence of a surge of cytokine expression is the driver of these processes. Induced expression of cluster of differentiation 147 (CD147) and TNF-α may also have a role. SARS-CoV-2 fluently harnesses the immune mechanisms of the host to its advantage, rendering it a formidable systemic pathogen. Future effective treatments are contingent upon improved aetiological understanding.
topic angiotensin-converting enzyme 2 (ace2)
cluster of differentiation (cd) 147
coronavirus disease (covid-19)
myocarditis
nadph oxidase
pneumonia
protein kinase r (pkr)
severe acute respiratory syndrome (sars)
url https://www.emjreviews.com/microbiology-infectious-diseases/article/primer-on-the-pathogenesis-of-severe-covid-19-part-two/
work_keys_str_mv AT thomasjwalsh primeronthepathogenesisofseverecovid19parttwo
_version_ 1721457072894115840